Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Multiple Myeloma Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Multiple Myeloma Drugsmarket, defines the market attractiveness level of Multiple Myeloma Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Multiple Myeloma Drugs industry, describes the types of Multiple Myeloma Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Multiple Myeloma Drugs market and the development prospects and opportunities of Multiple Myeloma Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Multiple Myeloma Drugs market in Chapter 13.
By Player:
Amgen
Merck
Novartis
Teva
Takeda Pharmaceutical
Johnson & Johnson
Celgene
AB Science
PharmaMar
Daiichi Sankyo
By Type:
Immunomodulatory drugs (IMiDs)
Proteasome inhibitors
Chemotherapy
Histone deacetylase inhibitor (HDAC inhibitor)
Steroids (corticosteroids)
By End-User:
Men
Women
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Multiple Myeloma Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Multiple Myeloma Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Multiple Myeloma Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Multiple Myeloma Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Multiple Myeloma Drugs Market Analysis and Outlook to 2022
-
7.1 Global Multiple Myeloma Drugs Consumption (2017-2022)
-
7.2 United States Multiple Myeloma Drugs Consumption (2017-2022)
-
7.3 Europe Multiple Myeloma Drugs Consumption (2017-2022)
-
7.4 China Multiple Myeloma Drugs Consumption (2017-2022)
-
7.5 Japan Multiple Myeloma Drugs Consumption (2017-2022)
-
7.6 India Multiple Myeloma Drugs Consumption (2017-2022)
-
7.7 South Korea Multiple Myeloma Drugs Consumption (2017-2022)
8 Region and Country-wise Multiple Myeloma Drugs Market Analysis and Outlook to 2028
-
8.1 Global Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.2 United States Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.4 China Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.6 India Multiple Myeloma Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Multiple Myeloma Drugs Consumption Forecast (2022-2028)
9 Global Multiple Myeloma Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Multiple Myeloma Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunomodulatory drugs (IMiDs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Proteasome inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Histone deacetylase inhibitor (HDAC inhibitor) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Steroids (corticosteroids) Consumption and Growth Rate (2017-2022)
-
9.2 Global Multiple Myeloma Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Men Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Women Consumption and Growth Rate (2017-2022)
10 Global Multiple Myeloma Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Multiple Myeloma Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunomodulatory drugs (IMiDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Proteasome inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Histone deacetylase inhibitor (HDAC inhibitor) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Steroids (corticosteroids) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Multiple Myeloma Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Men Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Women Consumption Forecast and Growth Rate (2022-2028)
11 Global Multiple Myeloma Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Multiple Myeloma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Multiple Myeloma Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Multiple Myeloma Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Multiple Myeloma Drugs Market Competitive Analysis
-
14.1 Amgen
-
14.1.1 Amgen Company Details
-
14.1.2 Amgen Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Multiple Myeloma Drugs Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Multiple Myeloma Drugs Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Multiple Myeloma Drugs Product and Service
-
14.4 Teva
-
14.4.1 Teva Company Details
-
14.4.2 Teva Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Multiple Myeloma Drugs Product and Service
-
14.5 Takeda Pharmaceutical
-
14.5.1 Takeda Pharmaceutical Company Details
-
14.5.2 Takeda Pharmaceutical Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Multiple Myeloma Drugs Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Multiple Myeloma Drugs Product and Service
-
14.7 Celgene
-
14.7.1 Celgene Company Details
-
14.7.2 Celgene Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Celgene Multiple Myeloma Drugs Product and Service
-
14.8 AB Science
-
14.8.1 AB Science Company Details
-
14.8.2 AB Science Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AB Science Multiple Myeloma Drugs Product and Service
-
14.9 PharmaMar
-
14.9.1 PharmaMar Company Details
-
14.9.2 PharmaMar Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 PharmaMar Multiple Myeloma Drugs Product and Service
-
14.10 Daiichi Sankyo
-
14.10.1 Daiichi Sankyo Company Details
-
14.10.2 Daiichi Sankyo Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Daiichi Sankyo Multiple Myeloma Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Multiple Myeloma Drugs
-
Figure Multiple Myeloma Drugs Picture
-
Table Global Multiple Myeloma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Myeloma Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Myeloma Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Multiple Myeloma Drugs Consumption by Country (2017-2022)
-
Figure United States Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Multiple Myeloma Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Myeloma Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Multiple Myeloma Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulatory drugs (IMiDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Proteasome inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Histone deacetylase inhibitor (HDAC inhibitor) Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids (corticosteroids) Consumption and Growth Rate (2017-2022)
-
Figure Global Men Consumption and Growth Rate (2017-2022)
-
Figure Global Women Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulatory drugs (IMiDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Proteasome inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Histone deacetylase inhibitor (HDAC inhibitor) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids (corticosteroids) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Men Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Women Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Multiple Myeloma Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Multiple Myeloma Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Multiple Myeloma Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Multiple Myeloma Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Multiple Myeloma Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Multiple Myeloma Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Multiple Myeloma Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Multiple Myeloma Drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Multiple Myeloma Drugs Product and Service
-
Table AB Science (Foundation Year, Company Profile and etc.)
-
Table AB Science Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AB Science Multiple Myeloma Drugs Product and Service
-
Table PharmaMar (Foundation Year, Company Profile and etc.)
-
Table PharmaMar Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmaMar Multiple Myeloma Drugs Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Multiple Myeloma Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Multiple Myeloma Drugs Product and Service
-
